Clostridium difficile

(redirected from Cdiff)
Also found in: Medical.

Clostridium difficile

(dɪˈfɪsɪli; ˌdɪfɪˈsiːl)
n
(Pathology) a faecal organism endemic in hospitals and responsible for the majority of hospital-acquired cases of diarrhoea in elderly patients. Sometimes shortened to: C.difficile or C.diff
References in periodicals archive ?
Cobas MRSA/SA is the fifth assay for use on the cobas Liat PCR System and joins cobas Cdiff as part of the HAI portfolio.
Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C.
Dr Wells said: "Faecal transplantation doesn't sound appealing but it's very effective with serious CDiff infection.
Dr Wells said: "Faecal transplantation doesn't sound very appealing but it's a very effective remedy in patients like Len who have a serious CDiff bowel infection than hasn't responded to first and second line treatments.
The latest figures show hospital acquired infections like MRSA and CDIFF showed a rate of zero per cent The 27-bed hospital, which celebrated its 25th anniversary last year and is part of the Spire Healthcare group, carries out 2,000 operations a year and employs 115 people.
The company also profited from a stronger flu season in 2013 and the FDA approvals of its BD Max Cdiff Assay in the United States, the BD ProbeTec Trichomonas Vaginalis Qx Amplified DNA Assay, and the nasopharyngeal wash, aspirate and swab in transport media specimens on the BD Veritor System for the rapid detection of respiratory syncytial virus.
Moeslein, RN, MSA, CIC, Infection Prevention Nurse Manager from Riverside Regional Medical Center, who will discuss 'Tales from the Trenches: How Our Facility Implemented and Evaluated UV Technology to Reduce MDROs and Cdiff.
M2 PHARMA-March 19, 2014-Roche unveils CE-IVD launch of cobas Cdiff Test
A SICK Midland patient died four days after hospital medics rejected her plea for a second test for the lethal CDiff superbug - because it was not 'cost effective'.
All discrepant stool samples with sufficient residual material maintained at -20[degrees]C were sent for supplemental testing at two outside laboratories using different commercially available PCR assays (GeneXpert C difficile/Epi assay [Cepheid Diagnostics, Sunnyvale, California] and Gene-Ohm Cdiff assay [BD Diagnostics, Franklin Lakes, New Jersey]).
Current available PCR assays include Becton, Dickinson and Company's GeneOhm Cdiff assay; Prodesse's ProGastro Cd assay; and Cepheid's Xpert[R] C.